3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Pericardial Effusion
Pericardial effusion refers to the abnormal accumulation of fluid in the pericardial sac, the double-walled sac that surrounds the heart. This condition can result from various causes, including infections, inflammation, trauma, or underlying medical conditions. As the fluid accumulates, it puts pressure on the heart, potentially impacting its ability to function optimally. Common symptoms of pericardial effusion include chest pain, shortness of breath, and fatigue. Diagnosis often involves imaging tests such as echocardiography, and treatment may vary based on the underlying cause. In some cases, medical intervention, such as drainage of the fluid or anti-inflammatory medications, may be necessary to alleviate symptoms and prevent complications. Pericardial effusion underscores the importance of timely medical attention and intervention in managing cardiovascular health.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain